Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

2.7K
2.7K
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

7.5K
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
7.5K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

8.8K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.8K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

3.2K
3.2K
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

11.2K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
11.2K
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

4.1K
4.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

EpiATLAS - a reference for human epigenomic research.

bioRxiv : the preprint server for biology·2026
Same author

Integration of the naive pluripotency gene network with the response to GSK3 inhibition by Tcf7l1-driven enhancer decommissioning.

Stem cell reports·2026
Same author

Development, characterization, and inter-laboratory validation of methylated human cell free DNA candidate reference materials.

Clinical epigenetics·2026
Same author

Scalable longitudinal imaging and transcriptomics of cells in dynamic enclosures.

bioRxiv : the preprint server for biology·2026
Same author

Programmable artificial RNA condensates in mammalian cells.

Nature nanotechnology·2026
Same author

The H3K36me3 methyltransferase SETD2 contributes to PAF1C interactions with RNA Pol II and is required for neuronal differentiation.

The EMBO journal·2026

相关实验视频

Updated: Mar 8, 2026

Single-Molecule Imaging of EWS-FLI1 Condensates Assembling on DNA
07:05

Single-Molecule Imaging of EWS-FLI1 Condensates Assembling on DNA

Published on: September 8, 2021

2.8K

转录因子的协同绑定调节重编程

Constantinos Chronis1, Petko Fiziev1, Bernadett Papp1

  • 1David Geffen School of Medicine, Department of Biological Chemistry, University of California Los Angeles, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, Jonsson Comprehensive Cancer Center, Bioinformatics Program, Los Angeles, CA 90095, USA.

Cell
|January 24, 2017
PubMed
概括

Oct4,Sox2,Klf4和cMyc (OSKM) 通过非活性化体力增强剂和选择多能增强剂来重新编程细胞. 这些过程由OSKM与特定阶段的转录因子相互作用来指导.

关键词:
一个Kf4十四月这样就好了有关合作的约束增强剂诱导多能干细胞多能性重编程转录因子

更多相关视频

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.5K
Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
10:28

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

Published on: September 20, 2018

7.0K

相关实验视频

Last Updated: Mar 8, 2026

Single-Molecule Imaging of EWS-FLI1 Condensates Assembling on DNA
07:05

Single-Molecule Imaging of EWS-FLI1 Condensates Assembling on DNA

Published on: September 8, 2021

2.8K
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.5K
Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
10:28

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

Published on: September 20, 2018

7.0K

科学领域:

  • 细胞重编程
  • 表观遗传学
  • 转录因子函数

背景情况:

  • Oct4,Sox2,Klf4和cMyc (OSKM) 是诱导体细胞多能性的关键转录因子.
  • 对于再生医学和发育生物学来说,了解OSKM调节的精确机制至关重要.

研究的目的:

  • 在细胞重编程过程中阐明OSKM功能的机械细节.
  • 在重编程过程中映射OSKM与染色体状态和阶段特异性转录因子的动态相互作用.

主要方法:

  • 对OSKM结合部位,转录因子结合和染色质状态的全基因组映射.
  • 功能损失和增益实验,以评估转录因子对重新编程效率的影响.

主要成果:

  • OSK转录因子早期结合了活性体质增强剂,从而启动了它们的全基因组无活化.
  • 人体转录因子的重新分配和Hdac1的招募伴随着人体增强剂的失活.
  • 多能增强剂的选择是一个由OSK早期启动并由其他多能因素进一步调节的阶段性过程.
  • 身体或多能性因子的过度表达会调节OSKM向和增强器动态,影响重编程效率.

结论:

  • OSKM和特定阶段的转录因子之间的协作相互作用对于指导体质增强剂无活化和多能增强剂选择至关重要.
  • 这些复杂的分子相互作用协调了复杂的细胞重编程过程.